Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?Reid F. Thompson, Charles R. Thomas, Seth A. Rosenthal et al.|Radiotherapy and Oncology|2018Cited by 252
Factors Associated With Age Disparities Among Cancer Clinical Trial ParticipantsEthan B. Ludmir, Clifton D. Fuller, W. Ian P. Mainwaring et al.|JAMA Oncology|2019Cited by 229
Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder CancerSamuel J. Wang, Charles R. Thomas, Andrew Lemieux et al.|Journal of Clinical Oncology|2011Cited by 219
Thymic carcinoma: state of the art reviewTony Y. Eng, Charles R. Thomas, Clifton D. Fuller et al.|International Journal of Radiation Oncology*Biology*Physics|2004Cited by 187
Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder CancerSamuel J. Wang, Peter M. Ravdin, Jong Sung Kim et al.|Journal of Clinical Oncology|2008Cited by 146